Citadel Advisors
RNVA

Citadel Advisors’s Rennova Health, Inc. RNVA Stock Holding History

Citadel Advisors’s Portfolio RNVA Stock Details RNVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-196
Closed -$7K – 8434
2016
Q4 		$7K Sell
196
-163
-45% -$9.26K ﹤0.01% 7162
2016
Q3 		$31K Buy
+359
New +$47.1K ﹤0.01% 6958
2016
Q2 		– Sell
-51
Closed -$18K – 7798
2016
Q1 		$18K Buy
51
+26
+104% +$9.55K ﹤0.01% 6503
2015
Q4 		$15K Buy
25
+22
+733% +$38K ﹤0.01% 8128
2015
Q3 		$11K Sell
3
-3
-50% -$8.17K ﹤0.01% 8447
2015
Q2 		$18K Buy
+6
New +$22.5K ﹤0.01% 8213
2015
Q1 		– Sell
-3
Closed -$7K – 9065
2014
Q4 		$7K Sell
3
-1
-25% -$3.27K ﹤0.01% 8220
2014
Q3 		$20K Buy
+4
New +$27.2K ﹤0.01% 7439
2014
Q2 		– Sell
-3
Closed -$37K – 8548
2014
Q1 		$37K Buy
+3
New +$47.5K ﹤0.01% 6970

Other funds holding RNVA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Citadel Advisors's RNVA Position: Q1 2017 in Review

Citadel Advisors sold out of Rennova Health, Inc. (RNVA) in Q1 2017, closing a stake of 196 shares — an estimated $7K sold.

Citadel Advisors first reported a position in RNVA in Q1 2014 and held it in 9 quarters. The position peaked at $37K in Q1 2014. 9 funds tracked by Wall St. Rank hold RNVA as of Q1 2017.

  • Citadel Advisors reported no remaining Rennova Health, Inc. position as of Q1 2017 after selling out during the quarter.
  • Citadel Advisors sold 196 Rennova Health, Inc. shares in Q1 2017, an estimated $7K.
  • Citadel Advisors first reported a position in Rennova Health, Inc. in Q1 2014 and held it in 9 quarters.
  • Citadel Advisors's Rennova Health, Inc. position peaked at $37K in Q1 2014.
  • 9 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q1 2017.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.